Follow
Michael MacAskill
Michael MacAskill
Senior Research Fellow, University of Otago, Christchurch
Verified email at otago.ac.nz - Homepage
Title
Cited by
Cited by
Year
PsychoPy2: Experiments in behavior made easy
J Peirce, JR Gray, S Simpson, M MacAskill, R Höchenberger, H Sogo, ...
Behavior Research Methods 51 (1), 195-203, 2019
36482019
The MoCA Well-suited screen for cognitive impairment in Parkinson disease
JC Dalrymple-Alford, MR MacAskill, CT Nakas, L Livingston, C Graham, ...
Neurology 75 (19), 1717-1725, 2010
9532010
The timing mega-study: Comparing a range of experiment generators, both lab-based and online
D Bridges, A Pitiot, MR MacAskill, JW Peirce
PeerJ 8, e9414, 2020
4662020
Eye movements in patients with neurodegenerative disorders
TJ Anderson, MR MacAskill
Nature Reviews Neurology 9 (2), 74-85, 2013
3512013
Grey matter atrophy in cognitively impaired Parkinson's disease
TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ...
Journal of Neurology, Neurosurgery & Psychiatry 83 (2), 188-194, 2012
3102012
Building experiments in PsychoPy, 2nd Ed.
J Peirce, R Hirst, M MacAskill
Sage, 2022
2992022
Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease
TR Melzer, R Watts, MR MacAskill, JF Pearson, S Rüeger, TL Pitcher, ...
Brain 134 (3), 845-855, 2011
2022011
Characterizing mild cognitive impairment in Parkinson's disease
JC Dalrymple‐Alford, L Livingston, MR MacAskill, C Graham, TR Melzer, ...
Movement Disorders 26 (4), 629-636, 2011
1842011
White matter microstructure deteriorates across cognitive stages in Parkinson disease
TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ...
Neurology 80 (20), 1841-1849, 2013
1772013
Eye movements in neurodegenerative diseases
MR MacAskill, TJ Anderson
Current opinion in neurology 29 (1), 61-68, 2016
1042016
Adaptive modification of saccade amplitude in Parkinson’s disease
MR MacAskill, TJ Anderson, RD Jones
Brain 125 (7), 1570, 2002
952002
Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study
CJL Heron, SL Wright, TR Melzer, DJ Myall, MR MacAskill, L Livingston, ...
Journal of Cerebral Blood Flow & Metabolism 34 (6), 964-970, 2014
812014
Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
KL Wood, DJ Myall, L Livingston, TR Melzer, TL Pitcher, MR MacAskill, ...
npj Parkinson's Disease 2 (1), 1-8, 2016
752016
The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease
MR MacAskill, CF Graham, TL Pitcher, DJ Myall, L Livingston, ...
Neuropsychologia 50, 3338-3347, 2012
722012
Don't look now or look away: Two sources of saccadic disinhibition in Parkinson's disease?
S van Stockum, M MacAskill, T Anderson, J Dalrymple-Alford
Neuropsychologia 46 (13), 3108-3115, 2008
652008
Beta amyloid deposition is not associated with cognitive impairment in Parkinson's disease
TR Melzer, MR Stark, RJ Keenan, DJ Myall, MR MacAskill, TL Pitcher, ...
Frontiers in neurology 10, 391, 2019
642019
Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
AJ Jones, RG Kuijer, L Livingston, D Myall, K Horne, M MacAskill, ...
Translational Neurodegeneration 6, 1-9, 2017
642017
Eye movements during transitive action observation have sequential structure
A Webb, A Knott, MR MacAskill
Acta psychologica 133 (1), 51-56, 2010
592010
Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of Parkinson patients: Potential treatment to improve insulin-like …
D Fan, Y Alamri, K Liu, M MacAskill, P Harris, M Brimble, ...
Nutrients 10 (6), 714, 2018
582018
Parkinson’s in the oldest old: Impact on estimates of future disease burden
DJ Myall, TL Pitcher, JF Pearson, JC Dalrymple-Alford, TJ Anderson, ...
Parkinsonism & related disorders 42, 78-84, 2017
462017
The system can't perform the operation now. Try again later.
Articles 1–20